Zobrazeno 1 - 10
of 13
pro vyhledávání: '"David Henault"'
Autor:
Ralph Saber, David Henault, Nouredin Messaoudi, Rolando Rebolledo, Emmanuel Montagnon, Geneviève Soucy, John Stagg, An Tang, Simon Turcotte, Samuel Kadoury
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-16 (2023)
Abstract Background Finding a noninvasive radiomic surrogate of tumor immune features could help identify patients more likely to respond to novel immune checkpoint inhibitors. Particularly, CD73 is an ectonucleotidase that catalyzes the breakdown of
Externí odkaz:
https://doaj.org/article/aae54557d28548c1ac9911badaa56469
Autor:
David Henault, David Stephen, Pierre-Antoine St-Hilaire, Nouredin Messaoudi, Franck Vandenbroucke-Menu, Eve Simoneau, Zhixia Rong, Marylène Plasse, Richard Létourneau, André Roy, Michel Dagenais, Réal Lapointe, Bich Nguyen, Anne-Marie Mes-Masson, G. Soucy, Simon Turcotte
Publikováno v:
OncoImmunology, Vol 12, Iss 1 (2023)
ABSTRACTIn colorectal cancer liver metastases (CRLM), the density of tumor-infiltrating lymphocytes, the expression of class I major histocompatibility complex (MHC-I), and the pathological response to preoperative chemotherapy have been associated w
Externí odkaz:
https://doaj.org/article/f7d6612e7f864920847bd437adcab85f
Autor:
Nouredin Messaoudi, Isabelle Cousineau, Elizabeth Arslanian, David Henault, David Stephen, Franck Vandenbroucke-Menu, Michel Dagenais, Richard Létourneau, Marylène Plasse, André Roy, Réal Lapointe, Dirk Ysebaert, Dominique Trudel, Geneviève Soucy, John Stagg, Simon Turcotte
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Immune checkpoint blockade has not yet been effective in patients with mismatch repair proficient metastatic colorectal cancer. Targeting immunosuppressive metabolic pathways is being explored as a new immunotherapeutic approach. We assessed whether
Externí odkaz:
https://doaj.org/article/a33e281651764b35a08a7c56c70ff606
Autor:
Nouredin Messaoudi, David Henault, David Stephen, Isabelle Cousineau, Eve Simoneau, Zhixia Rong, Richard Létourneau, Marylène Plasse, Michel Dagenais, André Roy, Réal Lapointe, Franck Vandenbroucke-Menu, Rastislav Kunda, Dirk Ysebaert, Geneviève Soucy, John Stagg, Peter Vermeulen, Simon Turcotte
Publikováno v:
Br J Cancer
BACKGROUND: After resection, colorectal cancer liver metastases (CRLM) surrounded by a desmoplastic rim carry a better prognosis than the metastases replacing the adjacent liver. However, these histopathological growth patterns (HGPs) are insufficien
Autor:
Simon Turcotte, Nouredin Messaoudi, André Roy, Isabelle Cousineau, Richard Letourneau, Franck Vandenbroucke-Menu, Réal Lapointe, David Henault, David Stephen, Geneviève Soucy, John Stagg, Dirk Ysebaert, Elizabeth Arslanian, Marylène Plasse, Michel Dagenais, Dominique Trudel
Publikováno v:
Oncoimmunology
OncoImmunology, Vol 9, Iss 1 (2020)
OncoImmunology, Vol 9, Iss 1 (2020)
Immune checkpoint blockade has not yet been effective in patients with mismatch repair proficient metastatic colorectal cancer. Targeting immunosuppressive metabolic pathways is being explored as a new immunotherapeutic approach. We assessed whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e58535bbb366274f872fe02b3d513edd
https://biblio.vub.ac.be/vubir/prognostic-value-of-cd73-expression-in-resected-colorectal-cancer-liver-metastasis(1822a243-3cce-4b4c-ab95-d09ef15d02a5).html
https://biblio.vub.ac.be/vubir/prognostic-value-of-cd73-expression-in-resected-colorectal-cancer-liver-metastasis(1822a243-3cce-4b4c-ab95-d09ef15d02a5).html
Autor:
Benoit Barrette, Antoine Bernard, Simon Turcotte, Pamela Thebault, David Henault, Sandy Pelletier
Publikováno v:
Journal for ImmunoTherapy of Cancer. 9:A325-A325
BackgroundMetastatic colorectal cancer (CRC) is common and lethal and generally not responsive to current immunotherapies. We hypothesize that efficacious T cell-based immunotherapy can be developed for this malignancy, provided that immune checkpoin
Autor:
Bich Nguyen, Geneviève Soucy, Pierre-Antoine St-Hilaire, Anne-Marie Mes-Masson, Elizabeth Arslanian, David Henault, David Stephen, Dominique Trudel, André Roy, Franck Vandenbroucke-Menu, Richard Letourneau, Simon Turcotte, Marylène Plasse, Isabelle Cousineau, Nouredin Messaoudi, Michel Dagenais, Réal Lapointe, John Stagg
3584Background: As approximately 80% of patients recur and die of their cancer after undergoing curative-intent resection of colorectal cancer liver metastasis (CRLM) combined with systemic chemoth...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9db689c504b27ecdb4c40e29f145a0c1
https://biblio.vub.ac.be/vubir/prognostic-value-of-cd73-expression-in-resected-colorectal-cancer-liver-metastasis(92beb81e-c24a-456a-8ec7-847e1a502b5d).html
https://biblio.vub.ac.be/vubir/prognostic-value-of-cd73-expression-in-resected-colorectal-cancer-liver-metastasis(92beb81e-c24a-456a-8ec7-847e1a502b5d).html
Autor:
David Henault, Sue-Ling Chang, Sinziana Dumitra, Robyn Tamblyn, Tracy Westley, Richard Kremer, Ari N. Meguerditchian, Nancy E. Mayo
Publikováno v:
Bone. 116
Purpose Older Breast Cancer (BC) survivors are an increased risk of osteoporosis due to natural aging and long-term cancer treatment-related toxicity. It is well known that anti-estrogen therapy (AET), especially aromatase inhibitors (AI), is associa
Autor:
Steven Hébert, Mélissa Mathieu, David Henault, Maud Marques, Éric Audemard, Mathieu Courcelles, Scott D. Brown, Pratyaksha Wirapati, Sabine Tejpar, Michael I. D'Angelica, Robert A. Holt, Sylvie Mader, Pierre Thibault, Gerald Batist, Claudia Kleinman, Simon Turcotte
Publikováno v:
Cancer Research. 79:579-579
Immunotherapy for patients with non-highly mutated, mismatch repair-proficient (MMRprof) metastatic colorectal cancer has largely been unsuccessful thus far. Here, we used transcriptomics, genomics and in vitro analyses to study the adaptive immune f
Autor:
David Henault, Trina A. Johnson, Lorna Galleguillos, Amit Bar-Or, Jack P. Antel, Craig S. Moore
Publikováno v:
Neurology. 81:1768-1772
Objective: To determine the range of fluctuation in total lymphocyte counts (TLCs) in peripheral blood over a 4- to 7-year period in patients with MS receiving fingolimod (FTY720) and the relation between TLCs and T-cell subsets (CD4+, CD8+, CCR7+/